Learn / AVBP
NASDAQ: AVBP
ArriVent BioPharma (AVBP) stock, explained like you're 5
ArriVent BioPharma trades on the Nasdaq under the ticker AVBP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 825 million dollars.
- Ticker
- AVBP
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 825 million dollars
Is ArriVent BioPharma a small, medium or large cap company?
No. ArriVent BioPharma is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 825 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How ArriVent BioPharma makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AVBP stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- ArriVent BioPharma, Inc. (AVBP) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- ArriVent BioPharma, Inc. (AVBP) stock price, news, quote and history (Yahoo Finance UK)
- ArriVent BioPharma (AVBP) Securities Investigation Notice Levi & Korsinsky (PR Newswire)
- A cancer drug targets two proteins in ovarian and endometrial tumors. Its first patient has been dosed. (Stock Titan)
- Why ArriVent BioPharma (AVBP) Stock Is Down Today (Quiver Quantitative)
Follow AVBP in your daily brief
Each trading day at 5 PM ET we post what happened to ArriVent BioPharma and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AVBP
Questions about ArriVent BioPharma stock
What does ArriVent BioPharma do?
ArriVent BioPharma trades on the Nasdaq under the ticker AVBP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 825 million dollars.
What is the ticker symbol for ArriVent BioPharma?
ArriVent BioPharma trades under the ticker AVBP on the Nasdaq.
What is ArriVent BioPharma's market cap?
ArriVent BioPharma is a small cap stock with a market cap of about 825 million dollars.
How does ArriVent BioPharma make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AVBP stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AVBP stock every day?
Add AVBP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.